Drug-resistant TB patients to get new med

To shorten the duration of treatment for drug-resistant TB patients (DRTB), the health department has launched an injectable-free Bedaquiline regimen.

Published: 03rd August 2021 07:09 AM  |   Last Updated: 03rd August 2021 07:09 AM   |  A+A A-

MBBS exam

For representational purposes

By Express News Service

BENGALURU: To shorten the duration of treatment for drug-resistant TB patients (DRTB), the health department has launched an injectable-free Bedaquiline regimen. Usually, DRTB patients do not respond to normal treatment of 3-4 injections daily.

“The regular medicines are given for 9 to 24 months. However, Bedaquiline is given only for 9 to 12 months. There are various kinds of drug-resistant TB patients and in Karnataka, the number is 3,000. Of these, 1,000 are Rifampicin (antibiotic) resistant. These patients will be administered Bedaquiline,” said Dr Ramesh Reddy, joint director, Tuberculosis.

A culture test is done to know which drug the person is resistant to. There are around 500 patients in the state who are resistant to multiple drugs. The initiative was launched on Monday by Dr Arundathi Chandrasekhar, director, National Health Mission, and is a step towards Kshaya Muktha (TB-free) Karnataka, the health department said.

Now we are on Telegram too. Follow us for updates
India Matters

Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

Videos
Gallery